175
Participants
Start Date
September 30, 2013
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
AZD6423
Drug: AZD6423 Single or Multiple doses via infusion.
Placebo
Placebo to match AZD6423 Single or Multiple doses of matching placebo delivered via infusion
Research Site, Glendale
Lead Sponsor
AstraZeneca
INDUSTRY